Open offer public announcement filed for Colinz Laboratories
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Saffron Capital Advisors Private Limited, acting as Manager to the Offer, has submitted a Public Announcement to BSE under SEBI Takeover Regulations 3(1) and 4 read with Regulations 13, 14 and 15(1). This filing indicates an open offer has been formally triggered for Colinz Laboratories, likely following a substantial acquisition of shares or change in control. Further details on offer price, size and timeline are expected in the detailed letter of offer.
Shareholders may get an exit opportunity at a prescribed offer price; expect price volatility and watch for the detailed letter of offer.